Recall Register

Food, drugs, devices › Philips Medical Systems (Cleveland) Inc

Device recall: BrightView SPECT gamma camera for Emission Computed Tomography, Philips Medical Systems, Cleveland, OH 44143 BrightView

FDA enforcement event 65140 · Class II · initiated 25 Apr 2013 · status Terminated · terminated 12 Feb 2014

DeviceVoluntary: Firm initiated1 product recordCleveland, OH

FDA enforcement event 65140 is a device recall by Philips Medical Systems (Cleveland) Inc of Cleveland, OH, initiated 25 Apr 2013 and classified Class II, with 1 product record.

FDA defines Class II as a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. 90% of the 1,236 device enforcement events initiated in 2013 carry the same class.

Status: Terminated, terminated 12 Feb 2014. Initiation: voluntary: firm initiated. Philips Medical Systems (Cleveland) Inc has 129 enforcement events on this register, with a median of 1 product record per event.

Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.

Recalling firm

Philips Medical Systems (Cleveland) Inc, Cleveland, OH.

Reason for recall

"Philips has received one report from the field that there was an unexpected motion of the detector due to a failure of the mechanical assembly."

Distribution

"Worldwide Distribution - USA including AK, AR, AZ, CA, CO, CT, DC, DE, FL, GA, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, NJ, NM, NV, NY, OH, OK, OR, PA, PR, SC, SD, TN, TX, VA,…"

Product records

Recall numberProductQuantityClassStatusReport date
Z-1481-2013BrightView SPECT gamma camera for Emission Computed Tomography, Philips Medical Systems, Cleveland, OH 44143 BrightView SPECT is a gamma camera designed for single or dual detector nuclear imaging accommodating a broad range of emission computed tomography Emission Computed Tomography (ECT) studies.505 unitsClass IITerminated12 Jun 2013

Context

90%of 2013 device events are Class II1,236 events that year
1product record in this eventfirm median: 1
129events on this register for the firm

Other enforcement events for Philips Medical Systems (Cleveland) Inc

InitiatedProduct (first record)TypeClassRecords
5 Aug 2025Pinnacle Radiation Therapy Planning System: Multimodality Simulation Workspace 18.0.5 Model 870258 UDI code: (01)0088483DeviceClass II1
17 Jul 2025Pinnacle 3 with TumorLOC, (870258) Radiation Therapy Planning System SoftwareDeviceClass II1
30 Aug 2022Pinnacle3 Radiation Therapy Planning System, Model numbers 870231 and 870237.DeviceClass II1
19 Sep 2019Forte Gamma Camera System is intended to produce images depicting the anatomical distribution of single-photon and positDeviceClass I5
24 Jun 2019Ingenuity CT, Model # 728326, computed tomography x-ray systemDeviceClass II9
10 Jun 2019BrightView SPECT, Model Number 882480DeviceClass II3
3 Jun 2019Vereos PET/CT, Model No. 882446 Product Usage: Positron Emission Tomography (PET) and X-ray Computed Tomography (CT) sysDeviceClass II1
19 Dec 2018Ingenuity TF PET/CT (non-RoHS), Model Number 882456 This device is a diagnostic imaging system that combines Positron EmDeviceClass II1
18 Oct 2018Brilliance 64, Model 728231 Product Usage: Computed Tomography X-ray systems intended to produce cross-sectional Images DeviceClass II6
4 Sep 2018Vereos PET/CT, Software version 2.0.1. Model Number: 882446 Product Usage: The Philips Vereos PET/CT system is a diagnosDeviceClass II1

All 129 events for Philips Medical Systems (Cleveland) Inc

Questions and answers

Why was this device recalled?

FDA's record gives the reason for recall as: "Philips has received one report from the field that there was an unexpected motion of the detector due to a failure of the mechanical assembly."

What does Class II mean?

FDA classifies recalls by relative degree of health hazard. Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.

Where was the product distributed?

FDA's distribution pattern field reads: "Worldwide Distribution - USA including AK, AR, AZ, CA, CO, CT, DC, DE, FL, GA, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, NJ, NM, NV, NY, OH, OK, OR, PA, PR, SC, SD, TN, TX, VA,…"

Is the recall still ongoing?

FDA lists the status as Terminated; the termination date is 12 Feb 2014. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.

Where does this data come from?

openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.

Provenance

Source: openFDA device enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.